Search Results

1-3 of 3 results for subject:"Pasteur Merieux"

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

To ask the Secretary of State for Health, if he will list the members of the Committee on Safety of Medicines who have, in each year from 1987 to date, declared outside interests in (a) SmithKline Beecham, (b) SmithKline and French laboratories, (c) Merck Sharpe and Dohme, (d) Pasteur Merieux...

Asked by

Norman Baker (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

29 February 2000

For answer on

7 March 2000

Answered on

7 March 2000

Mr. Baker: To ask the Secretary of State for Health if he will list the members of the Committee on Safety of Medicines who have, in each year from 1987 to date, declared outside interests in (a) SmithKline Beecham, (b) SmithKline and French laboratories, (c) Merck Sharpe and Dohme, (d) Pasteur Merieux and (e) the Wellcome Foundation. [112835] Ms Stuart: This information is published annually in the "Medicines Act 1968 Advisory Bodies--Annual Reports" copies of which, dating back to 1987, are available in the Library, The reports include lists of interests in the pharmaceutical industry declared by each committee member. The 1999 report, which is due to be published in July this year, will include the entries in the table relating to members of the Committee on Safety of Medicines (CSM) (this information is correct as at 6 March 2000). In addition, Professor J. H. Scarffe is Head of Programmes (Career Development) at the Wellcome Trust. _________________________________________________________________________________________________. CMS member Name of company Nature of interest Professor J. Chipman SmithKline Beecham Non-personal--research grants Professor J. Darbyshire SmithKline Beecham Non-personal--support for clinical trials Professor H. Dargie SmithKline Beecham Personal--consultancy and non-personal--clinical trial Dr. M. Donaghy SmithKline Beecham Personal--shareholder Dr. B. Evans SmithKline Beecham Personal--fees and shares Professor E. Gordon-Smith Pasteur-Merieux Non-personal--research grants Professor M. Langman Merck Sharpe and Dohme Non-personal--support/research collaborations Dr. A. MacGowan SmithKline Beecham Personal--consultancy and non-personal--fellowship Professor B. Park SmithKline Beecham Non-personal--lectureship Professor J. F. Smyth SmithKline Beecham Personal--occasional meetings and non-personal--clinical trials support Professor I. Weller SmithKline Beecham Non-personal--trials and study Professor K. Woodhouse SmithKline Beecham Non-personal--clinical research trials Merck Sharpe and Dohme Non-personal--clinical research trials _________________________________________________________________________________________________.

Date

7 March 2000

Reference

112835; 345 c630W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what contact he has had with the Pasteur Merieux Company concerning the withdrawal of general availability of the single measles vaccine.

Asked by

Llew Smith (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

19 October 1998

Reference

317 c977W; 55481

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what discussions his Department has had with Pasteur Merieux MSD to discuss the withdrawal of the single measles vaccination from the United Kingdom (a) before and (b) since the withdrawal was announced.

Asked by

Lord Brady of Altrincham (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

19 October 1998

Reference

55501; 317 c977W

House

House of Commons

Librarians' tools

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher